A multicenter Chinese study shows that an MRI-based nomogram combining clinical signs with AI-derived tumor habitat features can noninvasively predict high-risk hepatocellular carcinoma before surgery and stratify patients’ risk of recurrence.
A multicenter Chinese study shows that an MRI-based nomogram combining clinical signs with AI-derived tumor habitat features can noninvasively predict high-risk hepatocellular carcinoma before surgery and stratify patients’ risk of recurrence.
